Literature DB >> 20351627

Mechanisms of the beneficial effect of hypertonic saline solution in acute pancreatitis.

Ana Maria Mendonça Coelho1, José Jukemura, Sandra N Sampietre, Joilson O Martins, Nilza A T Molan, Rosely A Patzina, Björn Lindkvist, Sonia Jancar, José Eduardo M Cunha, Luiz A Carneiro D'Albuquerque, Marcel Cerqueira Cesar Machado.   

Abstract

Administration of hypertonic saline (HS) solution to rats with acute pancreatitis (AP) decreases mortality and systemic inflammation. We hypothesized that these effects are related not only to systemic inflammatory reduction, but also to a reduction of the pancreatic lesion. Acute pancreatitis was induced in Wistar rats by injection of 2.5% sodium taurocholate. Animals were divided in groups: without AP, not treated AP, AP treated with NaCl 0.9%, and AP treated with NaCl 7.5%. Trypsinogen activation peptides and amylase activity were increased in ascitic fluid and serum and were not affected by treatment with HS. Pancreatic inflammation was evaluated by increased myeloperoxidase activity, malondialdehyde formation, and histopathology for severity of pancreatic lesions. The HS did not affect these parameters. Expression of cyclooxygenase 2 and inducible nitric oxide synthase was markedly increased in the pancreas of the AP group and was reduced by treatment with HS. This treatment also reduced the levels of TNF-α and IL-6 but not of IL-10 in the pancreatic tissue. These results show that HS modulates cytokine production and expression of enzymes responsible for inflammatory mediator production in the pancreas without affecting the severity of the pancreatic lesions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351627     DOI: 10.1097/SHK.0b013e3181defaa1

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Effects of intravenous administration of pentoxifylline in pancreatic ischaemia-reperfusion injury.

Authors:  Edmond Raymond Le Campion; Jose Jukemura; Ana Maria Coelho; Rosely Patzina; Luiz Augusto Carneiro D'Albuquerque
Journal:  HPB (Oxford)       Date:  2012-12-17       Impact factor: 3.647

2.  Hypertonic saline and reduced peroxynitrite formation in experimental pancreatitis.

Authors:  Ester Correia Sarmento Rios; Ana Soares Moretti; Irineu Tadeu Velasco; Heraldo Possolo de Souza; Fatima Abatepaulo; Francisco Soriano
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Effect of ageing on systemic inflammatory response in acute pancreatitis.

Authors:  Marcel Cerqueira Cesar Machado; Ana Maria Mendonça Coelho; Luiz Augusto Carneiro D'Albuquerque; Sonia Jancar
Journal:  Int J Inflam       Date:  2012-01-15

4.  Sodium lactate improves renal microvascular thrombosis compared to sodium bicarbonate and 0.9% NaCl in a porcine model of endotoxic shock: an experimental randomized open label controlled study.

Authors:  Thibault Duburcq; Arthur Durand; Antoine Tournoys; Viviane Gnemmi; Valery Gmyr; François Pattou; Mercedes Jourdain; Fabienne Tamion; Emmanuel Besnier; Sebastien Préau; Erika Parmentier-Decrucq; Daniel Mathieu; Julien Poissy; Raphaël Favory
Journal:  Ann Intensive Care       Date:  2018-02-14       Impact factor: 6.925

5.  Comparison of hypertonic saline versus normal saline on cytokine profile during CABG.

Authors:  Mahnaz Mazandarani; Fardin Yousefshahi; Mohammad Abdollahi; Hadi Hamishehkar; Khosro Barkhordari; Mohammad Ali Boroomand; Arash Jalali; Arezoo Ahmadi; Reza Shariat Moharari; Mona Bashirzadeh; Mojtaba Mojtahedzadeh
Journal:  Daru       Date:  2012-10-08       Impact factor: 3.117

6.  Hypertonic saline mediates the NLRP3/IL-1β signaling axis in microglia to alleviate ischemic blood-brain barrier permeability by downregulating astrocyte-derived VEGF in rats.

Authors:  Qiao-Sheng Wang; Hong-Guang Ding; Sheng-Long Chen; Xin-Qiang Liu; Yi-Yu Deng; Wen-Qiang Jiang; Ya Li; Lin-Qiang Huang; Yong-Li Han; Miao-Yun Wen; Mei-Qiu Wang; Hong-Ke Zeng
Journal:  CNS Neurosci Ther       Date:  2020-06-12       Impact factor: 7.035

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.